مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients.

Authors : Robson, Helen; Anderson, Elizabeth; James, Roger D ...

Subjects: Colorectal Cancer; Biological Tumour Markers; Adenocarcinoma

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.

Authors : Mulder, W M; Stern, Peter L; Stukart, M J ...

Subjects: Cancer Antigens; Cancer Staging; Colorectal Cancer

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Measuring quality of life: impact of chemotherapy for advanced colorectal cancer. Experience from two recent large phase III trials.

Authors : Anderson, Heather; Palmer, Michael K; Christie Hospital, Withington, Manchester, UK.

Subjects: Colorectal Cancer; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Are differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe?

Authors : Woodman, Ciaran B J; Gibbs, Alan R; Scott, N ...

Subjects: Colorectal Cancer; Cancer Staging; Adenocarcinoma

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Developing effective cancer vaccines: design and monitoring are critical.

Authors : Armstrong, Anne C; Dermime, Said

Subjects: Colorectal Cancer; Antibodies; Anti-Idiotypic

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial.

Authors : Maughan, T S; James, Roger D; Kerr, David J ...

Subjects: Colorectal Cancer; Adenocarcinoma; Adult

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer.

Authors : Leonard, P; Seymour, M T; James, Roger D ...

Subjects: Diarrhoea; Colorectal Cancer; Cancer Metastasis

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

ZD1839 (Iressa): for more than just non-small cell lung cancer.

Authors : Ranson, Malcolm R; Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, United Kingdom.

Subjects: Breast Cancer; Colorectal Cancer; Ovarian Cancer

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer.

Authors : Braun, M S; Adab, Fawzi; Bradley, C ...

Subjects: Colorectal Cancer; Adult; Aged

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer.

Authors : Saunders, Mark P; Hogg, M; Carrington, Bernadette M ...

Subjects: Colorectal Cancer; Liver Cancer; Lung Cancer

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients.

Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.

Measuring quality of life: impact of chemotherapy for advanced colorectal cancer. Experience from two recent large phase III trials.

Are differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe?

Developing effective cancer vaccines: design and monitoring are critical.

Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial.

Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer.

ZD1839 (Iressa): for more than just non-small cell lung cancer.

Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer.

Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer.